- Home
- SLQT vs CRBP Comparison
SLQT vs CRBP Comparison
Compare SLQT & CRBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SLQT | CRBP |
|---|---|---|
| Founded | 1999 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 151.6M | 134.8M |
| IPO Year | 2020 | 2014 |
Fundamental Metrics
Financial Performance| Metric | SLQT | CRBP |
|---|---|---|
| Price | $0.79 | $8.23 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 7 |
| Target Price | $2.88 | ★ $46.17 |
| AVG Volume (30 Days) | ★ 1.7M | 146.3K |
| Earning Date | 05-11-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 105.00 | 64.31 |
| EPS | ★ 0.01 | N/A |
| Revenue | ★ $1,526,594,000.00 | $4,822,272.00 |
| Revenue This Year | $12.34 | N/A |
| Revenue Next Year | $7.64 | $220.00 |
| P/E Ratio | $85.75 | ★ N/A |
| Revenue Growth | 15.50 | ★ 97.62 |
| 52 Week Low | $0.81 | $4.64 |
| 52 Week High | $4.19 | $20.56 |
Technical Indicators
Market Signals| Indicator | SLQT | CRBP |
|---|---|---|
| Relative Strength Index (RSI) | 30.29 | 52.95 |
| Support Level | N/A | $7.77 |
| Resistance Level | $1.74 | $8.43 |
| Average True Range (ATR) | 0.08 | 0.49 |
| MACD | 0.01 | 0.13 |
| Stochastic Oscillator | 22.20 | 67.76 |
Price Performance
Historical ComparisonAbout SLQT SelectQuote Inc.
SelectQuote Inc is a Direct-to-consumer (DTC) distribution platform which facilitates consumers to shop for health, life and auto & home insurance policies online. The company generates its revenues by selling insurance products on behalf of the insurance carrier partners in the form of a commission. It has four reportable segments namely Senior, Healthcare Services, Life, and Auto & Home. It functions through three lines namely, SelectQuote Senior, SelectQuote Life, and SelectQuote Auto & Home.
About CRBP Corbus Pharmaceuticals Holdings Inc.
Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.